Astex Pharmaceuticals, Inc. (ASTX) Posts Surprise Q2 Profit

Astex Pharmaceuticals, Inc. (NASDAQ: ASTX) reported Q2 EPS of $0.01, $0.08 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $19.9 million versus the consensus estimate of $15.5 million.

For earnings history and earnings-related data on Astex Pharmaceuticals, Inc. (ASTX) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• zSpace, Inc. (ZSPC) Reports Q2 results
• Gemini Space Station, Inc. (GEMI) Misses Q2 EPS by 32c